Old Well Partners’s Solid Biosciences SLDB Stock Holding History

Old Well Partners’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,800	Closed	-$58.1K	–	37
2022 Q4	$58.1K	Buy	+10,800	New	+$70.8K	0.05%	32
2021 Q4	–	Sell	-2,261	Closed	-$81K	–	48
2021 Q3	$81K	Hold	2,261	–	–	0.04%	39
2021 Q2	$124K	Hold	2,261	–	–	0.06%	34
2021 Q1	$188K	Buy	+2,261	New	+$250K	0.09%	40
2020 Q3	–	Sell	-668	Closed	-$29K	–	39
2020 Q2	$29K	Hold	668	–	–	0.02%	29
2020 Q1	$24K	Hold	668	–	–	0.02%	29
2019 Q4	$45K	Buy	+668	New	+$73.7K	0.04%	31

Other funds holding SLDB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Old Well Partners's SLDB Position: Q1 2023 in Review

Old Well Partners sold out of Solid Biosciences (SLDB) in Q1 2023, closing a stake of 10,800 shares — an estimated $58.1K sold.

Old Well Partners first reported a position in SLDB in Q4 2019 and held it in 7 quarters. The position peaked at $188K in Q1 2021. 39 funds tracked by Wall St. Rank hold SLDB as of Q1 2023.

Old Well Partners reported no remaining Solid Biosciences position as of Q1 2023 after selling out during the quarter.
Old Well Partners sold 10,800 Solid Biosciences shares in Q1 2023, an estimated $58.1K.
Old Well Partners first reported a position in Solid Biosciences in Q4 2019 and held it in 7 quarters.
Old Well Partners's Solid Biosciences position peaked at $188K in Q1 2021.
39 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2023.

Based on Old Well Partners's 13F filing for Q1 2023, filed 15 May 2023.